Advances in treatment of Vogt-Koyanagi-Harada syndrome / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science
;
(12): 1082-1086, 2017.
Article
Dans Chinois
| WPRIM
| ID: wpr-641218
ABSTRACT
Vogt-Koyanagi-Harada (VKH)syndrome is an autoimmune disease attacking against pigmented cells, resulting in blindness and usually affecting multiple organs including ears, meninges, hair and skin.Correct diagnosis and immediate treatment in the early stage is vital to visual prognosis.Currently, corticosteroids is first-line drug.In addition, VKH patients refractory to corticosteroids can choose other treatment such as immunosuppressive agents and biological agents.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
International Eye Science
Année:
2017
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS